A carregar...
Impact of disease‐modifying drugs on the severity of COVID‐19 infection in multiple sclerosis patients
Recent evidence suggested that neurological manifestations occur in patients with a severe form of coronavirus disease (COVID‐19). On the basis of this issue, neurologists are very concerned about patients with neurological disorders, especially multiple sclerosis (MS), as consumers of immunosuppres...
Na minha lista:
| Publicado no: | J Med Virol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675642/ https://ncbi.nlm.nih.gov/pubmed/33044760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26593 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|